Goodness Growth Holdings Signs Definitive Agreement to Acquire Charm City Medicus Dispensary in Baltimore, Maryland

Goodness Growth Holdings签署最终协议,收购马里兰州巴尔的摩的魅力城医疗药房

2021-07-20 23:01:30 CFN Media Group

本文共2161个字,阅读需6分钟

– Transaction will improve scale in Maryland’s medical cannabis market by expanding retail dispensary footprint – – Company expects to transition Charm City Medicus to Green Goods™ retail dispensary brand post-closing –     MINNEAPOLIS, July 9, 2021 /PRNewswire/ — Goodness Growth Holdings, Inc. (“Goodness Growth” or the “Company”) (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced that its subsidiary, Vireo of Charm City, LLC, has signed a definitive agreement to purchase all substantial assets of Charm City Medicus, LLC, a medical cannabis dispensary located in Baltimore, Maryland.   “We are very pleased to be expanding our retail market share in Maryland’s medical cannabis market and look forward to introducing our Green Goods™ dispensary brand to the Baltimore area,” said Chairman and Chief Executive Officer, Kyle Kingsley, M.D. “With our recent initiatives to expand cultivation and processing capacity in Maryland, we’re in an excellent position to continue growing our wholesale and retail sales in the state as our manufacturing capabilities enable us to offer the full spectrum of cannabis products to patients. We also plan to leverage this new location to support engagement activities in the local community through our expungement clinics and other social events.”   The Company expects the transaction to close later this year, pending approval of the dispensary license transfer by the Maryland Medical Cannabis Commission. The Company expects total consideration for the transaction at closing of US $8.0 million, including $4.0 million in cash, $2.0 million in Goodness Growth stock, and a $2.0 million promissory note issued to the seller. Goodness Growth shares issued in conjunction with the transaction will be subject to a one-year lock-up agreement. Upon closing of the transaction, the Company expects to transition Charm City to the Green Goods™ brand of retail dispensaries.   About Goodness Growth Holdings, Inc. Goodness Growth Holdings, Inc., is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The Company’s operations consist primarily of its multi-state cannabis company subsidiary, Vireo Health, and its science and intellectual property developer, Resurgent Biosciences. The Company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites and distributes its products through its growing network of Green Goods™ and other retail locations and third-party dispensaries. Its teams of more than 500 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines, and developing meaningful intellectual property. Today, the Company is licensed to grow, process, and/or distribute cannabis in eight markets and operates 17 dispensaries across the United States. For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com.     Contact Information Investor Inquiries: Media Inquiries: Sam Gibbons Albe Zakes Vice President, Investor Relations Vice President, Corporate Communications [email protected] [email protected] (612) 314-8995 (267) 221-4800     Forward-Looking Statement Disclosure This press release contains “forward-looking information” within the meaning of applicable United States and Canadian securities legislation. To the extent any forward-looking information in this press release constitutes “financial outlooks” within the meaning of applicable United States or Canadian securities laws, such information is being provided as preliminary financial results and the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such financial outlooks. Forward-looking information contained in this press release may be identified by the use of words such as “plan,” “position,” “continue,” “will,” “expects,” “pending,”or variations of such words and phrases.  These statements should not be read as guarantees of future performance or results. Forward-looking information includes both known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company or its subsidiaries to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements or information contained in this press release. Forward-looking information is based upon a number of estimates and assumptions of management, believed but not certain to be reasonable, in light of management’s experience and perception of trends, current conditions, and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.   Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, risks related to current and future economic conditions; risks related to the COVID-19 pandemic; federal, state, local, and foreign government laws, rules, and regulations, including federal and state laws in the United States relating to psychedelics  and any changes to such laws; operational, regulatory, and other risks; execution of business strategy; difficulty to forecast; conflicts of interest; liquidity and additional financing; and risk factors set out in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, which is available on EDGAR with the U.S. Securities and Exchange Commission and filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.   The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results, or otherwise, other than as required by applicable securities laws. SOURCE Goodness Growth Holdings     This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
-交易将通过扩大零售药房的足迹来提高马里兰州医用大麻市场的规模- -公司期望将魅力城药房转型为绿色商品™零售药房品牌关闭后- 明尼阿波利斯2021年7月9日电/PRNewswire/--Goodness Growth Holdings,Inc.(“Goodness Growth”或“公司”)(CSE:GDNS;OTCQX:GDNSF)是一家以医生为主导、专注于科学的大麻公司和IP开发商,今天宣布其子公司Charm City,LLC的Vireo已签署最终协议,购买位于马里兰州巴尔的摩的医用大麻药房Charm City Medicus,LLC的所有实质性资产。 “我们很高兴扩大我们在马里兰医用大麻市场的零售市场份额,并期待着将我们的绿色商品™药房品牌引入巴尔的摩地区,”董事长兼首席执行官凯尔·金斯利医学博士说“随着我们最近在马里兰州扩大种植和加工能力的举措,我们处于一个绝佳的位置,可以继续增长我们在该州的批发和零售销售,因为我们的制造能力使我们能够向患者提供全系列大麻产品。我们还计划利用这一新位置,通过我们的清除诊所和其他社会活动来支持当地社区的参与活动。“ 该公司预计交易将于今年晚些时候结束,等待马里兰州医用大麻委员会批准药房许可证转让。该公司预计交易的总对价为美国800万美元,包括400万美元现金、200万美元Goodness Growth股票和向卖方发行的200万美元期票。与本次交易同时发行的优益成长股份将受一年锁定协议约束。于交易完成后,本公司预期将Charm City转型为零售药房的绿色商品™品牌。 关于Goodness Growth控股公司。 Goodness Growth Holdings,Inc.是一家以医生为主导,专注于科学的控股公司,其使命是将植物的力量带到世界。该公司的业务主要由其多州大麻公司子公司Vireo Health及其科学和知识产权开发商复兴生物科学公司组成。该公司在环保设施和最先进的种植场所制造专有的品牌大麻产品,并通过其日益增长的绿色商品™网络和其他零售点及第三方药房分销其产品。其500多名员工的团队专注于差异化产品的开发,推动植物药物的科学创新,并开发有意义的知识产权。今天,该公司被许可在八个市场种植、加工和/或分销大麻,并在美国经营17个药房。欲了解更多关于Goodness Growth Holdings的信息,请访问www.goodnessgrowth.com。 联系方式 投资者咨询: 媒体询问: 萨姆·吉本斯 阿尔贝扎克斯 副总裁,投资者关系 公司传讯副总裁 [电子邮件受保护] [电子邮件受保护] (612)314-8995 (267)221-4800 前瞻性陈述披露 本新闻稿包含适用的美国和加拿大证券立法含义内的“前瞻性信息”。如果本新闻稿中的任何前瞻性信息构成适用的美国或加拿大证券法意义上的“财务展望”,该等信息是作为初步财务结果提供的,请读者注意,该信息可能不适用于任何其他目的,读者不应过度依赖该财务展望。本新闻稿中包含的前瞻性信息可以通过使用诸如“计划”、“立场”、“继续”、“将要”、“预期”、“待定”等词或这些词和短语的变体来识别。这些声明不应被理解为对未来业绩或结果的保证。前瞻性信息包括已知和未知的风险、不确定性和其他因素,这些因素可能导致本公司或其子公司的实际结果、业绩或成就与本新闻稿中所包含的前瞻性陈述或信息所表达或暗示的任何未来结果、业绩或成就存在重大差异。前瞻性资料是根据管理层的经验和对趋势、当前状况和预期发展的看法,以及与当时情况有关的其他因素,包括对当前和未来市场状况、当前和未来监管环境的假设,作出的若干估计和假设,认为但不一定合理;以及许可证、批准书和许可证的可用性。 虽然本公司相信该等前瞻性资料所依据的预期及假设是合理的,但不应过度依赖该等前瞻性资料,因为本公司无法保证该等资料将被证明是正确的。实际结果和发展可能与这些陈述所预期的有重大差异。前瞻性信息受到各种风险和不确定性的影响,这些风险和不确定性可能导致实际事件或结果与前瞻性信息中预测的事件或结果大相径庭。此类风险和不确定性包括但不限于与当前和未来经济状况有关的风险;与新冠肺炎疫情相关的风险;联邦、州、地方和外国政府的法律、规则和条例,包括美国与迷幻药有关的联邦和州法律以及对这些法律的任何修改;运营、监管和其他风险;企业战略的执行;难以预测;利益冲突;流动性和额外融资;以及本公司截至2020年12月31日止年度的10-K表年度报告中列出的风险因素,该报告可在美国证券交易委员会的EDGAR上查阅,并向加拿大证券监管机构提交,并可在www.SEDAR.com的SEDAR上查阅本公司的简介。 本新闻稿中的声明截至本新闻稿发布之日。除适用证券法规定外,本公司概无任何意图或义务更新任何前瞻性信息,无论是由于新信息、未来事件或结果,还是其他原因。 源优成长控股 本文由CFN Enterprises Inc.(OTCQB:CNFN)发表,该公司是CFN Media的所有者和运营商,CFN Media是行业领先的机构和数字金融媒体网络,致力于新兴的CBD和合法大麻行业。请致电+1(833)420-CNFN了解更多信息。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文